Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





REGEN4HD Trial

Neurology
Ravi Rajmohan
PHASE 1B/2A STUDY OF THE SAFETY AND TOLERABILITY OF HUMAN NEURAL STEM CELLS FOR HUNTINGTON'S DISEASE (REGEN4HD)
Huntingtons Disease

Study Description

The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.

Eligibility

Have decision-making capacity and be able to provide written informed consent.

Are between 18 to 65 years of age

Have genetically confirmed diagnosis of Huntington's Disease

Able to undergo MRI scans, tolerate neurosurgical procedure, blood draws and lumbar puncture.

Are pregnant

Test positive for human immunodeficiency virus (HIV), hepatitis C or chronic hepatitis B at Screening

Have an implanted deep brain stimulation device.

A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.